Drug Shortage Report for JAMP CALCIUM POLYSTYRENE SULFONATE
Report ID | 207347 |
Drug Identification Number | 02502631 |
Brand name | JAMP CALCIUM POLYSTYRENE SULFONATE |
Common or Proper name | Calcium Polystyrene Sulfonate Powder |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | CALCIUM POLYSTYRENE SULFONATE |
Strength(s) | 999MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | RECTAL ORAL |
Packaging size | 300 g |
ATC code | V03AE |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-10-16 |
Estimated end date | 2024-12-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-03-30 | French | Compare |
v3 | 2024-03-30 | English | Compare |
v2 | 2023-10-18 | French | Compare |
v1 | 2023-10-18 | English | Compare |
Showing 1 to 4 of 4